| pubmed-article:12649518 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C1543694 | lld:lifeskim |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C0948008 | lld:lifeskim |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C0025872 | lld:lifeskim |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C2004454 | lld:lifeskim |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:12649518 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:12649518 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12649518 | pubmed:dateCreated | 2003-4-4 | lld:pubmed |
| pubmed-article:12649518 | pubmed:abstractText | We hypothesized that technetium-99m-ethylene dicysteine-metronidazole (99mTc-EC-MN) localizes to brain tissue that is hypoxic but viable. This study prospectively evaluated the relationship between neurological outcome and uptake of 99mTc-EC-MN in peri-infarcted regions of the brain. | lld:pubmed |
| pubmed-article:12649518 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12649518 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12649518 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12649518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12649518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12649518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12649518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12649518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12649518 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12649518 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12649518 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:KimE EdmundEE | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:BomHee-SeungH... | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:YangDavid JDJ | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:SeoJeong-JinJ... | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:KimChang-Guhn... | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:SongHo-ChunHC | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:ChoKi HyunKH | lld:pubmed |
| pubmed-article:12649518 | pubmed:author | pubmed-author:KimByeong... | lld:pubmed |
| pubmed-article:12649518 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12649518 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:12649518 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12649518 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12649518 | pubmed:pagination | 982-6 | lld:pubmed |
| pubmed-article:12649518 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:meshHeading | pubmed-meshheading:12649518... | lld:pubmed |
| pubmed-article:12649518 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12649518 | pubmed:articleTitle | Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole. | lld:pubmed |
| pubmed-article:12649518 | pubmed:affiliation | Department of Nuclear Medicine, Chonnam National University Hospital, 8 Hak-Dong, Dong-Gu, Gwangju, South Korea. | lld:pubmed |
| pubmed-article:12649518 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12649518 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12649518 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
